Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.

作者: Virginia Macdonald , Gregory J. Dore , Janaki Amin , Ingrid van Beek

DOI: 10.1071/SH06008

关键词: Vaccination scheduleAcquired immunodeficiency syndrome (AIDS)MedicineGenital wartsPublic healthFamily medicineHepatitis CVaccinationHepatitis BCohortImmunology

摘要: Background: In Australia, rates of hepatitis B (HBV) transmission continue to be higher in certain populations, including commercial sex workers and injecting drug users (IDU). This study aims identify predictors completion a HBV vaccination schedule ‘high-risk’ attendees primary health care centre Sydney. Methods: All clients who attended Kirketon Road Centre, located Kings Cross, Sydney, with no evidence immunity were included the cohort. The design was observational historical controls. main outcome measure three-dose vaccine period. Results: Among 2085 received first vaccination, 1013 (49%) second 435 (21%) third vaccination. Univariate analysis found that significant intention administer an accelerated (OR 1.49, P = 0.004), not being IDU 1.29, 0.02) shorter time between visit dose 1.24, for trend <0.0001); however, on multivariate analysis, longer predictor completion. Conclusion: Implementation improved but they still low, despite provision free service specifically targeting needs workers, other marginalised populations. Increasing uptake Australian adults is important public issue only prevention also future application potential vaccines, those against HIV C.

参考文章(20)
Bronwyn Anderson, Neil J Bodsworth, Richard A Rohrsheim, Basil J Donovan, Hepatitis B virus infection and vaccination status of high risk people in Sydney: 1982 and 1991. The Medical Journal of Australia. ,vol. 161, pp. 368- 371 ,(1994) , 10.5694/J.1326-5377.1994.TB127489.X
John M Kaldor, Aileen J Plant, Sandy C Thompson, Helen Longbottom, Jill Rowbottom, The incidence of hepatitis B infection in Australia: an epidemiological review. The Medical Journal of Australia. ,vol. 165, pp. 322- 326 ,(1996) , 10.5694/J.1326-5377.1996.TB124993.X
Carolyn Day, Kate Dolan, Joanne Ross, Bethany White, Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney. Australian and New Zealand Journal of Public Health. ,vol. 27, pp. 558- 558 ,(2003)
Bruno Marchout, Nicole Picot, Pascal Chavanet, Jean C. Auvergnat, Maxime Armengaud, Philippe Devilliers, Jean E. Cerisier, F.N. Marié, Jean L. Excler, Three-week hepatitis B vaccination provides protective immunity. Vaccine. ,vol. 11, pp. 1383- 1385 ,(1993) , 10.1016/0264-410X(93)90165-T
Anke Richter, Susan E. Anton, Peter Koch, Susan L. Dennett, The impact of reducing dose frequency on health outcomes Clinical Therapeutics. ,vol. 25, pp. 2307- 2335 ,(2003) , 10.1016/S0149-2918(03)80222-9
Gerald Y. Minuk, Dong Feng Sun, Rebecca Greenberg, Manna Zhang, Kimberly Hawkins, Julia Uhanova, Adam Gutkin, Kevin Bernstein, Antonio Giulivi, Carla Osiowy, Occult hepatitis B virus infection in a North American adult hemodialysis patient population Hepatology. ,vol. 40, pp. 1072- 1077 ,(2004) , 10.1002/HEP.20435
I van Beek, R Buckley, M Stewart, M MacDonald, J Kaldor, Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Sexually Transmitted Infections. ,vol. 70, pp. 321- 324 ,(1994) , 10.1136/STI.70.5.321
LISA MAHER, KERRY CHANT, BIN JALALUDIN, PENNY SARGENT, Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia Journal of Gastroenterology and Hepatology. ,vol. 19, pp. 1114- 1120 ,(2004) , 10.1111/J.1440-1746.2004.03438.X
Belinda G. O'Sullivan, Heather F. Gidding, Matthew Law, John M. Kaldor, Gwendolyn L. Gilbert, Gregory J. Dore, Estimates of chronic hepatitis B virus infection in Australia, 2000 Australian and New Zealand Journal of Public Health. ,vol. 28, pp. 212- 216 ,(2004) , 10.1111/J.1467-842X.2004.TB00697.X